- Home
- OSW vs CLDX Comparison
OSW vs CLDX Comparison
Compare OSW & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSW
- CLDX
- Stock Information
- Founded
- OSW N/A
- CLDX 1983
- Country
- OSW Bahamas
- CLDX United States
- Employees
- OSW N/A
- CLDX N/A
- Industry
- OSW Hotels/Resorts
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- OSW Consumer Discretionary
- CLDX Health Care
- Exchange
- OSW Nasdaq
- CLDX Nasdaq
- Market Cap
- OSW 2.1B
- CLDX 1.8B
- IPO Year
- OSW N/A
- CLDX 2008
- Fundamental
- Price
- OSW $20.18
- CLDX $25.14
- Analyst Decision
- OSW Strong Buy
- CLDX Buy
- Analyst Count
- OSW 4
- CLDX 7
- Target Price
- OSW $20.00
- CLDX $64.83
- AVG Volume (30 Days)
- OSW 535.8K
- CLDX 1.1M
- Earning Date
- OSW 10-30-2024
- CLDX 11-06-2024
- Dividend Yield
- OSW 0.40%
- CLDX N/A
- EPS Growth
- OSW 2284.58
- CLDX N/A
- EPS
- OSW 0.50
- CLDX N/A
- Revenue
- OSW $872,619,000.00
- CLDX $9,976,000.00
- Revenue This Year
- OSW $13.42
- CLDX N/A
- Revenue Next Year
- OSW $8.66
- CLDX N/A
- P/E Ratio
- OSW $40.60
- CLDX N/A
- Revenue Growth
- OSW 13.60
- CLDX 128.55
- 52 Week Low
- OSW $11.98
- CLDX $22.93
- 52 Week High
- OSW $20.57
- CLDX $53.18
- Technical
- Relative Strength Index (RSI)
- OSW 60.32
- CLDX 42.64
- Support Level
- OSW $19.37
- CLDX $23.94
- Resistance Level
- OSW $20.56
- CLDX $26.66
- Average True Range (ATR)
- OSW 0.57
- CLDX 1.36
- MACD
- OSW -0.05
- CLDX -0.07
- Stochastic Oscillator
- OSW 74.34
- CLDX 25.48
About OSW OneSpaWorld Holdings Limited
OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts worldwide. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.